Tolvaptan: A New Therapeutic Agent

E-ISSN： 1876-1038|6|2|177-188

ISSN： 1574-8871

Source： Reviews on Recent Clinical Trials, Vol.6, Iss.2, 2011-05, pp. : 177-188

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Therapeutic effects of short‐ and intermediate‐term tolvaptan administration for refractory ascites in patients with advanced liver cirrhosis

HEPATOLOGY RESEARCH, Vol. 45, Iss. 11, 2015-11 ,pp. : 1062-1070

John Wiley & Sons Inc

Access to resources Recommend Favorite

Buclizine, A New Tranquilizing Agent

JOURNAL OF AMERICAN GERIATRICS SOCIETY, Vol. 7, Iss. 1, 1959-01 ,pp. : 67-70

John Wiley & Sons Inc

Access to resources Recommend Favorite

Use of carbon monoxide as a therapeutic agent: promises and challenges

By Foresti Roberta Bani-Hani Mohamed Motterlini Roberto

Intensive Care Medicine, Vol. 34, Iss. 4, 2008-04 ,pp. : 649-658

Springer Publishing Company

Access to resources Recommend Favorite

Donepezil, a potential therapeutic agent for heart failure

EUROPEAN JOURNAL OF HEART FAILURE, Vol. 17, Iss. 2, 2015-02 ,pp. : 233-233

John Wiley & Sons Inc

Access to resources Recommend Favorite

A New Moral Agent: The Patient Advocate

By Iltis Ana Smith

The Journal of Medicine and Philosophy, Vol. 27, Iss. 6, 2002-12 ,pp. : 699-701

Oxford University Press

Access to resources Recommend Favorite